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Summary 
Fas-deficient lpr and gld mice develop lymphadenopathy due to the accumulation of T cells with 
an unusual double negative (DN) (CD4-CDS-)  phenotype. Previous studies have shown that 
these abnormal cells are capable of inducing redirected lysis of certain Fc receptor-positive target 
cells. Since the Fas ligand (FasL) has recently  been shown to be partly responsible for T cell-mediated 
cytotoxicity, lymph node cells from lpr and gld mice were examined for the expression of FasL 
mKNA. Northern blot analysis revealed that lymph node cells obtained from Ipr and gld mice 
had a striking increase in the level of expression of FasL mRNA predominantly due to expression 
in the DN T  cells. Furthermore, Ipr, but not g/d lymph node cells killed the B cell line,  A20, 
in a Fas-dependent manner. These findings indicate that Fas mutations result in a massive up- 
regulation of FasL which, most likely, results from repetitive exposure to (self) antigen. This 
phenomenon could explain the Ipr-induced wasting syndrome observed when lpr bone marrow-. 
derived cells are adoptively transferred to wild-type recipients. 
M 
ice with  spontaneous mutations of the Fas receptor 
(FasK) (MRL/Ipr and CBA/II,:s) or its ligand (FasL) 
(C3H/gld) develop lymphadenopathy and systemic autoim- 
munity (1, 2). While these phenotypic abnormalities can be 
explained by defects in Fas-mediated lymphocyte apoptosis, 
the pathogenesis of a chronic GVHD-like wasting syndrome 
induced by the adoptive transfer of Ipr bone marrow into syn- 
geneic hosts  (3,  4) remains to be clarified. 
Coculture of normal- and Ipr-derived T  cell lines results 
in the loss of the normal T cells in in vitro cultures (5). Since 
the FasL has recently been shown to have a cytotoxic effector 
function (6), overexpression of FasL in Ipr lymphocytes could 
explain these in vitro findings as well as the wasting syn- 
drome induced by Ipr bone marrow transfers (3, 4). In this 
report we directly demonstrate that FasL is markedly increased 
in the lymphoid tissues derived from older Ipr and g/d mice. 
The increased FasL expression is most likely due to repeated 
antigenic stimulation of T cells that cannot undergo apop- 
tosis through the Fas pathway. 
Materials  and Methods 
Mice.  MRL/Ipr  (MR~L/MpJ-lpr/Ipr),  MRL/Mp-+/+ 
(MRL/+ +), C3H (C3H/HeSnJ), and C3H/g/d (C3H/gld/gkl) mice 
were originally obtained from The Jack  son Laboratory (Bar Harbor, 
ME) and subsequently  bred at the Hospital for Special Surgery (New 
York).  The  mutant  strain,  CBAIIp:8  (CBA/KIJms/ 
lln~/Ip:s ) and the wild-type, CBA/+ +  (CBA/KIJms) have been 
described in detail previously (7). 
Cell Culture and Subset Isolation.  Single  cell suspensions were 
prepared from the thymus, spleen, lymph nodes and, in some cases, 
bone marrow from different strains of mice. To induce expression 
of FasL, splenic T cells were activated by Con A 2 #g/ml and Ib2 
(20 ng/ml) (8). The cells were cultured at 37~  in a humidified 
atmosphere in 5% CO2 at a density of 106 cells/ml in RPMI 1640 
containing 10% FCS and 50 #M 2-ME. After 2 d in culture, the 
cells were further stimulated by PMA (10 ng/ml) and ionomycin 
(500 ng/ml) for 4 h. A toxic shock syndrome (TSST)-reactive T 
cell line (>99%  CD4 §  isolated from splenic T  cells from an 
MRL/+ +  mouse was kindly provided by Drs. S. Friedman and 
J. Tumang, Hospital for Special Surgery. 
Cell subsets were isolated from the enlarged lymph nodes of 
4-5-mo-old Ipr mice by negative selection. To obtain an enriched 
population of CD4-, CD8- double negative (DN) T cells, CD4+ 
and CD8 § single positive (SP) T cells were depleted by incuba- 
tion of total lymph node cells with a cocktail of anti-CD4  and 
anti-CD8  mAb for 45 min at 4~  followed by incubation with 
guinea pig complement  (Cedarlane Laboratories, Inc.,  Hornby, 
Canada) for I h at 37~  Residual SP T and B cells were removed 
by magnetic  beads (Dynal,  Oslo,  Norway)  coated with  sheep 
anti-rat Ig. SP lymph node T cells were enriched by negative selec- 
tion. DN T cells coated with the anti-B220 mAb as well as B cells 
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polystyrene plates coated with anti-rat Ig. Residual antibody-coated 
cells were depleted with anti-rat Ig-coated magnetic beads as de- 
scribed above. 
Cytotoxicity  Studies.  Unfractionated lymph node cells were used 
as effector cells and the Fas § and Fas-  B cell lines, A20 (9) and 
1880 (10) were used as targets.  1@ target cells were labeled with 
SlCr for 2 h at 37~  Freshly isolated lymph node cells were in- 
cubated with 104 S1Cr-labeled target cells in triplicate at E/T ratios 
of 80, 40, 20, and 10:1 in round bottom 96-well microtiter plates 
at 37~  After 4-6 h, the cells were pelleted by centrifugation and 
the supematant counted in a "y counter. SlCr release was calculated 
from the formula: 100 x  (test release -  spontaneous release)/(max- 
imum release-  spontaneous  release). 
cDNA Probes  and DNA Sequencing.  A 1-kb cDNA probe en- 
coding the FasR was produced from MRL/+ +  thymus as described 
previously (11). To obtain cDNA probes encoding the FasL from 
rat (8) and mouse (2), splenocytes from a Spragne-Dawley rat (ac- 
tivated with Con A [2 #g/ml] for 24 h at 37~  and unmanipu- 
lated lymph node cells from an MRL/Ipr mouse, were obtained. 
Total RNA was isolated by the acid guanidinium method (12) and 
cDNA was synthesized with Moloney murine leukemia virus re- 
verse  transcriptase  and  oligo-dT  as described  (11). cDNA  was 
amplified by PCR on a 480 thermal cycler (Perkin-Elmer  Cetus 
Instruments, Norwalk, CT) with Taq polymerase. The primers used 
for PCR amplification of the FasL were (all in 5'-3' orientation): 
rat, sense CAACTCTTTCATCTACAGAAGGAACT  and antisense 
AAGCTTATATAAGCCAAAAAAGG  and mouse,  sense CATG- 
CAGCAGCCCATGAATTAC and  antisense  CCATGGACCTC- 
GAGAAAATGAAGG.  PCR  products  were  subcloned  and  se- 
quenced by the dideoxy chain termination method. 
Northern Blot  Analysis.  After electrophoresis of 10/~g of total 
RNA on a 1.2% denaturing agarose gel, RNA was blotted to nylon 
membranes  (Zeta Probe; Bio-Rad Laboratories, Richmond, CA). 
Hybridizations  and  washes  were  performed  according  to  the 
manufacturer's instructions at 65~  except that the rat FasL cDNA, 
which contains 93% sequence identity to the mouse FasL (2), was 
washed at 50~  The blots were sequentially probed with cDNAs 
encoding FasL, FasR, and the housekeeping  gene, glyceraldehyde 
phosphate dehydrogenase (GAPDH). The membranes were stripped 
between each probe. The levels of mRNA expression were deter- 
mined by laser densitometry (Molecular Dynamics, Sunnyvale, CA) 
analysis of the autoradiographs  and were expressed as the ratio of 
Fas/GAPDH  x  100. 
mA b and Flow Cytometry  Analysis.  Hybridomas specific  for the 
following cell-surface markers: Thyl.2 (HO-13-14), CD4 (GK1.5), 
CD8 (116-3.1), B220 (RA3-3A1/6.1), were obtained from the Amer- 
ican Type Culture Collection (Rockville,  MD).  The mAb were 
conjugated to FITC or to biotin and flow cytometry performed 
as described (13). The following secondary antibodies  were pur- 
chased:  FITC-conjugated  goat  (Fab')~ anti-mouse  IgM  (#- 
chain-specific),  FITC-conjugated mouse (Fab')~ anti-rat IgG (Fc 
fragment-specific), PE- and FITC-conjugated streptavidin (all from 
Jackson ImmunoResearch Laboratories,  Inc.,  West  Grove, PA). 
T  cells,  result in the reduced survival of the normal T  cells 
(5)  in vitro.  Both of these findings could be explained by 
the expression of a cytotoxic molecule on Ipr, but  not gtd, 
T  cells.  Since the FasL has recently been shown to induce 
apoptosis on FasR + targets (8)  and the lymph node DN T 
cells of MRL/Ipr mice induce redirected lysis on FcR-positive 
target cells (6), we examined the possibility that DN T cells 
express  high levels  of FasL. 
When the freshly isolated lymphoid organs from 4-5-mo- 
old normal mice were analyzed for the expression of FasL 
mRNA by Northern blot analysis using the rat FasL probe, 
little or no FasL expression was observed in the thymus, spleen 
(Fig.  1),  or lymph nodes (not  shown),  in agreement with 
the report by Takahashi et al. (2). This finding differs from 
FasR where the levels of receptor expression are modulated 
at varying stages of lymphocyte maturation (13,  15). In con- 
trast, massive upregulation of the FasL mRNA was observed 
in the thymus and lymph nodes (m50-fold) and, to a lesser 
extent, the spleens (m20-fold) obtained from 4-5-mo-old Ipr 
strains of mice (MILL and CBA)  as well as gld mice (Fig. 
1). Similar levels of FasL mRNA expression were observed 
in individual organs in all three strains at this age. The levels 
of FasL expression were barely above background in freshly 
isolated, normal splenic lymphocytes activated by Con A (Fig. 
1) or Con A,  PMA,  and ionomycin (Fig.  2 A)  or splenic 
Results and Discussion 
FasL Expression Is Strikingly Increased  in the Lymphoid Organs 
of Older lpr and g/d Mice.  Adoptive transfers of Ipr (1,  2), 
but not g/d (14), bone marrow induces a GVHD-like wasting 
syndrome in wild-type recipients.  Similarly,  cocultures  of 
MKL/Ipr and normal T  cells, but not MRL/gld and normal 
Figure  1.  Striking  increase in FasL  expression  by Northern blot anal- 
ysis. 10/zg of total RNA was applied to each lane of a 1% agarose gel 
containing 2.2 M formaldehyde.  After transfer to a nylon membrane, hy- 
bridization was performed  with a 32p-labeled  FasL  cDNA probe (RFasL). 
The membrane was stripped and successively  rehybridized  with cDNA 
probes for GAPDH, mouse FasL (MFasL),  and mouse FasR. All of the 
samples were obtained from mice aged 4-5 too. The results shown are 
representative of at least three similar experiments. 
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mice (not shown) indicating that the striking levels of FasL 
expression in the mutant mice are unlikely to be explained 
by mild or transient cell activation.  The levels of FasL ex- 
pression in Ipr and gid lymph nodes were approximately two- 
fold higher than that observed in the superantigen-reactive, 
MRL/++  CD4*  T  cell  line  triggered with  PMA  and 
ionomycin or superantigen 4 h before RNA isolation (Fig. 
2 B). Since the level of FasL expression would be expected 
to be fairly uniform in the recently activated T cell line, this 
finding suggests that the FasL is expressed at high levels in 
the majority of lymph node cells. 
Since the nucleotide sequence of the rat FasL (8) was pub- 
lished before that of the mouse FasL (2), Northern blots were 
initially performed with the rat FasL probe. To confirm the 
resuhs, all the blots were stripped, reprobed with the mouse 
FasL probe, and washed under high stingency conditions. The 
size of the FasL (*2 kb) and relative intensities of the signals 
between samples were identical for the rat and mouse probes 
(Fig.  1). 
Figure 2.  FasL  mRNA expression at different ages and in cell subsets. 
(/1) CD4+ and CDS+  single positive cells (SP) (96% purity) were iso- 
lated by depletion of B220+  cells from lymph nodes obtained from a 4- 
mo-old MRL/Ipr  mouse. The Ipr thymocytes were obtained from 4-wk-old 
MRL/Ipr and CBA/It~ mice and can be compared to FasL expression in 
a 4-too-old C3H/g/d mouse (lane I ). Splenocytes obtained from a 3-mo- 
old CBA mouse were incubated with Con A (2/zg/ml) and [52 (20 ng/ml) 
for 2 d followed by PMA (10 ng/ml) (P) and ionomycin (500 ng/ml) (I) 
for  4  h.  (B)  A  CD4 +  TSST-l-reactive  T  cell line derived  from  an 
MRL/+ +  mouse was activated by TSST-1 and rested for 7 d. After  7 
d, the line was either stimulated with PMA and ionomycin (TCL  +  P 
+ I) (as in A), retriggered with TSST-1  in the presence of  irradiated splenic 
antigen presenting cells (TCL  +  sag), or used without further stimula- 
tion (TCL). Total lymph node (LN) cells  and double negative (DN) lymph 
node cells were obtained from 4-mo-old lpr mice as described in Materials 
and Methods. As a control, RNA was obtained from the spleen of a 1-yr- 
old C3H mouse (C3H). Northern blot analysis  was performed as in Fig. 1. 
FasL Is Expressed on Both SP and DN Ipr and gld Lymph 
Node T  Cells.  The lymph nodes of older Ipr and gld mice 
comprise predominantly DN T cells (16). We therefore ex- 
amined whether FasL expression was present exclusively in 
the DN T  cell subset.  After SP and DN T cell isolation by 
negative sdection, flow cytometry analysis revealed that the 
purity of the isolated populations varied between 80 and 96% 
(results not shown). When cells that were >95% pure were 
analyzed for FasL expression by Northern blot analysis, the 
level of FasL expression in the DN T  cell population (Fig. 
2 B) was similar to, and the SP T  cell population (Fig.  2 
A) approximately half the level in total lymph node. It has 
recently been suggested that DN T cells arise from SP T cells 
that have been activated by sdf antigen and induced to down- 
regulate the CD4 or CD8 coreceptor (17). High levels of 
FasL expression on DN T ceils would therefore be expected 
if, as discussed brow, FasL is upregulated after antigenic stim- 
ulation and the cells fail to die. We propose that lymph node 
SP T cells that also express increased FasL have encountered 
antigen and are destined to downmodulate their coreceptors. 
Since the thymus of these mouse strains become progressively 
infiltrated with mature T  cells (18), increased FasL expres- 
sion in the thymus of older mice may be explained by similar 
mechanisms. 
Regulation of the Fas Receptor and Ligand.  Based on the 
results of adoptive bone marrow transfer experiments, Allen 
et al. (14) first proposed that the lpr and gld phenotypes resulted 
from mutations in a receptor ligand pair. They also postu- 
lated that the receptor and ligand were reciprocally regulated. 
The increase in FasL expression observed in MRL/Ipr mice 
is  compatible with  a  feedback  model of regulation since 
MRL/Ipr mice express little or no FasR protein (13, 19) due 
the insertion of a retrotransposon in the FasR gene (11, 20, 
21). We reasoned that if there was reciprocal regulation of 
the receptor ligand pair, then FasL expression should also be 
increased in young MRL/Ipr mice.  However,  as shown in 
Fig. 2 A, ligand expression was virtually undetectable in the 
thymus and spleen of 4-wbold Ipr mice. Furthermore, the 
increase in FasL expression was comparable in 4-mo-old lpr 
and C3H/gld mice (with a mutated FasL [2]) (Fig.  1). To 
explore this hypothesis more thoroughly, we rehybridized 
the Northern blots with the FasR cDNA probe (Fig. 1). As 
expected, FasR mRNA expression in tissues obtained from 
MRL/Ipr mice was very low (Fig. 1). In contrast to the striking 
upregulation of the FasL observed in lpr and gld mice, the 
level of FasR expression  was not significantly  increased  in 
the  lymphoid  organs  of  older  mice  (Figs.  1  and  3). 
Significantly, FasR mRNA expression in C3H/gld mice was 
not higher when compared to CBA/Ipr:s or normal mice 
(Fig. 3). Taken together, these data indicate that Fas receptor 
and ligand are not reciprocally regulated in Ipr and gld mice. 
Cytotoxic Activity of lpr L)/mph Node Cells and Relevance to 
the Ipr-induced Wasting Syndrome.  As discussed above, DN 
T cells have  previously been shown to exert cytotoxic activity 
in a redirected cytotoxicity assay although little or no killing 
was observed in the absence of antibodies to the effector cells 
(6). Since DN cells expressed perforin mRNA, it was assumed 
that  the cytotoxicity was  mediated through  the perforin 
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blot analysis of total RNA obtained from lpr and gld mice was performed 
as described as in Fig. 1. The levels of expression were quantified by laser 
densitometry  and expressed as: FasR/GAPDH  x  100. The analysis was 
performed  on mice aged between 16 and 20 wk (three  in each group). 
pathway (6). Since at least some of the targets tested (EL-4, 
P815) in that study express FasR ([22] and our unpublished 
observations), we examined whether the FasL expressed on 
/pr lymph node cells could directly kill a cell line that ex- 
presses very high levels  of FasR, A20 (23). As shown in Fig. 4 
A, unfractionated lymph node cells from 4-mo-old CBA/Ipr~ 
mice induced killing of theFasR + B cell line, A20, but not 
the FasR-  B cell line, 1881. Virtually identical results were 
obtained with age-matched MRL/Ipr lymph node cells (not 
shown). Complete inhibition of killing by a FasR-Ig fusion 
protein (kindly provided by Dr. S.-T. Ju, Boston University, 
Boston, MA) and failure of age-matched C3H/gld (or wild- 
type [not shown]) lymph node cells to kill the A20 cell line 
(Fig. 4 A) indicate that the killing was exclusively through 
the Fas pathway. Selective killing of the A20,  but not the 
1881, line was also produced with the agonist anti-FasR an- 
tibody, Jo2 (19) (Fig. 4 B). Detection of cytotoxic activity 
by lpr lymph node cells in the absence of anti-CD3 triggering 
in the present study may be explained by the very high levels 
of FasR or other cell surface molecules that facilitate FasL- 
mediated cytotoxicity  on the target, A20.  It is likely that 
the cytotoxidty observed in the previous study (6) is aug- 
mented (perhaps by stimulating perforin release) by pretrig- 
gering DN T cells through the T cell receptor or adhesion 
molecules. 
The striking increase in FasL mRNA expression and Fasb 
mediated cytotoxic activity of Ipr-derived lymph node cells 
strongly suggest that expression of the ligand is a major factor 
responsible for the in vivo wasting syndrome and in vitro 
loss of normal cells in lpr cocultures discussed above. These 
findings do not exclude a role for other cytokines known to 
be secreted by ll:r  DN T cells (24). The relatively mild induc- 
tion of wasting after  the  adoptive  transfer  of lp:g bone 
marrow into wild-type hosts may be explained by the binding 
of the FasL to the defective FasR of the donor lymphocytes 
leaving little free cytotoxic FasL to damage host cells. If this 
explanation is correct, then FasR must be expressed on radio- 
resistant cells of the bone marrow recipients. Immunohisto- 
chemical analysis of human tissue indicate that, in addition 
to lymphocytes, FasR (APO-1) is expressed on various mesen- 
chymal and histiocytic cells, especially in areas of inflamma- 
tion (25). Interestingly,  FasR was also detected in the skin, 
liver, and gastrointestinal tract (25): target organs for GVHD. 
We propose that after adoptive transfers of Ipr bone marrow, 
mature lpr-derived T cells are exposed to (self) antigen and 
upregulate FasL expression. Since these cells with abnormally 
high levels of the ligand cannot die by the Fas pathway, they 
persist and induce apoptosis on radioresistant  host cells or 
release cytokines such as y-IFN which upregulate FasR ex- 
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Figure 4.  lpr, but not g/d, lymph 
node cells are cytotoxic. (A) Lymph 
node  cells  from  4-too-old 
CBA/Ipr~g  (Ipr)  and  C3H/gld  (gld) 
mice were isolated and used as effec- 
tors (E) in a cytotc~icity assay. The 
FasR + B cell line,  A20,  and  the 
FasR-  B cell line,  1881, were la- 
beled with slCr and used as targets 
(T).  The cells were  incubated  at 
37~  for 4-6 h, centrifuged,  and 
the specific lysis calculated. Cyto- 
toxicity was also performed in the 
presence of 3 t~g of FasR fusion pro- 
tein (FP).  The results  shown are 
representative of three experiments 
performed. (B) A20 and 1881 target 
cells were prepared as in A and were 
incubated with the anti-FasR anti- 
body, Jo2, for 4-6 h at 37~  Spe- 
cific lysis was calculated as in A. 
396  Fas Ligand Expression  in lpr and g/d Mice pression on mesenchymal cells. Apoptosis of host cells results 
in the removal of supportive stromal and other mesenchymal 
cells necessary for survival of the immune system. Induction 
of apoptosis in FasR + cells in the skin, liver, and gastroin- 
testinal tract therefore simulates GVHD and suggests that 
the Fas cytotoxic pathway may also be involved in GVHD. 
Implications  for Fas Regulation and Apoptosis of  Activated Lym- 
phocytes in Normals.  The levels of expression  of FasL and 
FasR in normal mice and the changes in expression  noted 
in Fas mutant mice suggest the following series of events. 
When normal T  cells are activated, they express  FasR (as 
shown [13, 26, 27]) and FasL (8). However, since the receptor 
is not functional for several days after activation (28), the cells 
undergo clonal expansion. As the FasK becomes functional, 
the ligand kills activated cells. In view of the marked differ- 
ence in the level of FasL expression in mitogen-activated total 
splenic lymphocytes and mitogen-activated T cell line noted 
here,  repetitive stimulation or differentiation of T  cells to- 
ward the Thl subset (29) may be required for maximal ligand 
expression.  It would be expected that most of the killing is 
"fratricide" although, since receptor and ligand can both be 
expressed  on activated T  cells, a "suicide" pathway cannot 
be excluded. In this way, the Fas pathway limits expansion 
of activated cells and would be expected to be important for 
the removal of cells with potential for self reactivity. 
Whle the results obtained in this and a previous study 
(8)  indicate that FasL can kill in  an  antigen-independent 
fashion, the role of antigen recognition and other costimula- 
tory signals  remain important areas for further study. 
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